// App-Quantinova.ai

PB0600 : ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection

Researchers

Presenter

  • S. MacDonald

Principal Investigators

  • D. White

  • S. Cox-Morton

  • M. Sharp

  • T. Edwards

  • C. Moore

  • E. Vilar

  • M. Besser

  • E. Symington

  • M. Robinson

  • W. Thomas

Medical Centers

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • University of Hertfordshire, Hatfield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved